Alpha 2.0
Login Register
» Authors » Christopher A Waker

Christopher A Waker

Explore the profile of Christopher A Waker including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 84
Followers 0
Related Specialties
Oncology
General Medicine
Biology
Top 10 Co-Authors
Thomas L Brown
Robert M Lober
Melissa R Kaufman
Chanel Keoni
David H Gutmann
Madison L Stone
Yi-Hsien Chen
Ran Chen
Renee E Albers
Scout Bowman-Gibson
Published In
Front Physiol
Neoplasia
Stem Cells Dev
Adv Exp Med Biol
Theriogenology
Affiliations
Soon will be listed here.
Recent Articles
1.
Streamlined Analysis of Maternal Plasma Indicates Small Extracellular Vesicles are Significantly Elevated in Early-Onset Preeclampsia
Bowman-Gibson S, Chandiramani C, Stone M, Waker C, Rackett T, Maxwell R, et al.
Reprod Sci . 2024 May; 31(9):2771-2782. PMID: 38777947
Preeclampsia (PE) is a leading cause of maternal and fetal mortality and morbidity. While placental dysfunction is a core underlying issue, the pathogenesis of this disorder is thought to differ...
2.
Mouse models of preeclampsia with preexisting comorbidities
Waker C, Hwang A, Bowman-Gibson S, Chandiramani C, Linkous B, Stone M, et al.
Front Physiol . 2023 Apr; 14:1137058. PMID: 37089425
Preeclampsia is a pregnancy-specific condition and a leading cause of maternal and fetal morbidity and mortality. It is thought to occur due to abnormal placental development or dysfunction, because the...
3.
Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
Waker C, Kaufman M, Brown T
Front Physiol . 2021 Jul; 12:681632. PMID: 34276401
Preeclampsia (PE) is a multisystemic, pregnancy-specific disorder and a leading cause of maternal and fetal death. PE is also associated with an increased risk for chronic morbidities later in life...
4.
Erratum to "KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production" [Neoplasia, Volume: 21, Issue:1, (2019) 52-60]
Chen R, Keoni C, Waker C, Lober R, Chen Y, Gutmann D
Neoplasia . 2020 Feb; 22(3):e1. PMID: 32098655
No abstract available.
5.
Brain Tumors of Glial Origin
Waker C, Lober R
Adv Exp Med Biol . 2019 Nov; 1190:281-297. PMID: 31760651
Gliomas are a heterogeneous group of tumors with evolving classification based on genotype. Isocitrate dehydrogenase (IDH) mutation is an early event in the formation of some diffuse gliomas, and is...
6.
KIAA1549-BRAF Expression Establishes a Permissive Tumor Microenvironment Through NFκB-Mediated CCL2 Production
Chen R, Keoni C, Waker C, Lober R, Chen Y, Gutmann D
Neoplasia . 2018 Dec; 21(1):52-60. PMID: 30504064
KIAA1549-BRAF is the most frequently identified genetic mutation in sporadic pilocytic astrocytoma (PA), creating a fusion BRAF (f-BRAF) protein with increased BRAF activity. Fusion-BRAF-expressing neural stem cells (NSCs) exhibit increased...
7.
Gestational differences in murine placenta: Glycolytic metabolism and pregnancy parameters
Albers R, Waker C, Keoni C, Kaufman M, Bottomley M, Min S, et al.
Theriogenology . 2017 Nov; 107:115-126. PMID: 29145065
The placenta is a complex and essential organ composed largely of fetal-derived cells, including several different trophoblast subtypes that work in unison to support nutrient transport to the fetus during...
8.
AMPK Knockdown in Placental Labyrinthine Progenitor Cells Results in Restriction of Critical Energy Resources and Terminal Differentiation Failure
Waker C, Albers R, Pye R, Doliboa S, Wyatt C, Brown T, et al.
Stem Cells Dev . 2017 Mar; 26(11):808-817. PMID: 28335680
Placental abnormalities can cause Pregnancy-Associated Disorders, including preeclampsia, intrauterine growth restriction, and placental insufficiency, resulting in complications for both the mother and fetus. Trophoblast cells within the labyrinthine layer of...